Skip to main content
. Author manuscript; available in PMC: 2020 May 6.
Published in final edited form as: Mol Pharm. 2019 Mar 28;16(5):1881–1889. doi: 10.1021/acs.molpharmaceut.8b01246

Figure 2. Plasma concentration-time profile of curcumin-O-glucuronide.

Figure 2

Concentration-time profile of curcumin-O-glucuronide (COG) as described by a one-compartment model. Experimental observation data are shown as the mean +/− SD and the solid line represents the Phoenix WinNonlin model predicted curves after a 4 g oral dose of curcumin to 12 healthy subjects.